Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.17 (
PCE
)
1,301
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Flux
in non-aqueous-phase liquid (NAPL)-contaminated systems containing active microbial populations (including Dehalococcoides sp.) was investigated using a quantitative mass balance and phase distribution approach. Batch systems containing mixed NAPL with an initial tetrachloroethene (
PCE
) mole fraction ranging from 0.1 to 0.4 provided a means for comparing systems where mass transfer and aqueous concentration were controlled by the initial NAPL composition. Although the use of mixed NAPL with increasing
PCE
mole fractions introduced a mass-transfer variable on the abiotic dissolution rate, it was determined that biological systems produced flux rates that were similar to each other regardless of the initial
PCE
mole fraction. Thus, organisms appeared to be dechlorinating near their maximum conversion rates, and the result was the accumulation of cis-1,2-dichloroethene (cDCE) followed by slow conversion to vinyl chloride (VC). Increases in the initial
PCE
mole fractions in the NAPL had a negative impact on product distribution due to the presence of a larger concentration of a more favorable electron acceptor. Because the mass converted to cDCE was present largely in the dissolved phase in all systems, the production of this metabolite was a favorable outcome in terms of NAPL dissolution. The pH dropped as low as 4.9 in active systems, indicating that the amount of HCl released during the reductive dechlorination process was large enough to overwhelm the buffering capacity. This pH effect was more pronounced in systems that exhibited extensive dechlorination to VC, further suggesting that rapid dechlorination of
PCE
NAPL can alter chemical characteristics in source zone regions.
...
PMID:Flux and product distribution during biological treatment of tetrachloroethene dense non-aqueous-phase liquid. 1511 2